Synthesis and cytotoxicity of a biotinylated CC-1065 analogue
Open Access
- 1 January 2002
- journal article
- Published by Springer Nature in BMC Chemical Biology
- Vol. 2 (1) , 1
Abstract
The use of pretargeting technology for cancer imaging and treatment has made significant progress in the last few years. This approach takes advantage of the fact that biotin binds strongly to proteins avidin and streptavidin. Thus, a non-toxic tumor cell specific antibody is conjugated with avidin/streptavidin, and is administered to patients. After the antibody binds to tumor cells (usually 24–48 h); a clearing agent is given to remove the residual circulating antibodies in blood. Lastly, a toxic biotin-radioisotope conjugate is administered. Due to the small size of the biotin-radioisotope molecule and tight binding between biotin and avidin/streptavidin, the biotin-radioisotope rapidly binds to tumor cells with high specificity. CC-1065 (1) is one of a few classes of extremely potent antitumor agents, and a biotinalyted CBI-bearing CC-1065 analogue is a promising candidate to be used in the pretargeting technology to treat cancer. A biotinalyted CBI-bearing CC-1065 analogue, 6, was synthesized. The IC50 of 6 was 0.7 nM against U937 cells. Compound 6 caused apototsis of U937 cells. For the first time, a biotinalyted CBI-bearing CC-1065 analogue, 6, was synthesized. The biotinylated 6 can serve as a model compound to explore the usefulness of non-radioactive small molecule anticancer drugs in the pretargeting strategy for cancer imaging and therapy.Keywords
This publication has 22 references indexed in Scilit:
- Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and 131I-labeled bivalent hapten.2000
- Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer.2000
- Pretargeting strategies for radio-immunoguided tumour localisation and therapyEuropean Journal of Cancer, 1997
- Radioiodine therapy of the autonomous thyroid nodule in patients with or without visible extranodular activity.1995
- Intraperitoneal radio‐localization of tumors pre‐targeted by biotinylated monoclonal antibodiesInternational Journal of Cancer, 1990
- [5] Avidin and streptavidin1990
- INVESTIGATIONS OF AVIDIN AND BIOTIN FOR IMAGING APPLICATIONS1987
- Structure of CC-1065 (NSC-298223), a new antitumor antibiotic.The Journal of Antibiotics, 1980
- CC-1065 (NSC-298223), a new antitumor antibiotic. Production, in vitro biological activity, microbiological assays and taxonomy of the producing microorganism.The Journal of Antibiotics, 1978
- Avidin1975